Ashish Nimgaonkar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ashish nimgaonkar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ashish Nimgaonkar Today - Breaking & Trending Today

India Seeks Bigger Foothold In Pharmaceutical Industry As Drugmakers Look Beyond China

India s global market share in the pharmaceutical business is expected to grow and is estimated to exceed $130 billion by 2030. ....

New Delhi , United States , Tommy Erdei , Chandra Ganjoo , Atmanirbhar Bharat , Ashish Nimgaonkar , International Business Times , Piramal Pharma Solutions , Aragen Life Sciences , Sai Life Sciences , Pharmaceuticals Export Promotion Council , Bacillus Calmette Gu , Glyscend Therapeutics , Life Sciences , Trivitron Healthcare , International Business , Atmanirbhar Bharat , Economy Markets ,

Indian drug manufacturers benefit from Big Pharma interest beyond China

Indian drug manufacturers benefit from Big Pharma interest beyond China
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

United States , Peter Deyoung , Ashish Nimgaonkar , Helen Chen , Indian Cdmos , Piramal Pharma , Ramesh Subramanian , Tommy Erdei , Aragen Life Sciences , Sai Life Sciences , Drug Administration , Piramal Pharma Solutions , Glyscend Therapeutics , Greater China Managing Partner , Mordor Intelligence , Life Sciences ,

India gains as Big Pharma looks beyond China

Drugmakers are reducing their reliance on Chinese contractors and turning to manufacturers in India for clinical trials and early-stage manufacturing, as tensions with China and concerns over supply chain exposure increase. ....

United States , City Of , United Kingdom , Andhra Pradesh , Ramesh Subramanian , Catherine Evans , Andrew Silver , Rishika Sadam , Tommy Erdei , Piramal Pharma , Peter Deyoung , Indian Cdmos , Helen Chen , Maggie Fick , Ashish Nimgaonkar , Michele Gershberg , Drug Administration , Piramal Pharma Solutions , Aragen Life Sciences , Sai Life Sciences , Glyscend Therapeutics , Greater China Managing Partner , Mordor Intelligence , Life Sciences , Big Pharma ,

FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers
are seeking to limit their reliance on Chinese contractors who
produce drugs used in clinical trials and early-stage
manufacturing, a move that is benefiting rivals in India,
according to. ....

United States , City Of , United Kingdom , Andhra Pradesh , Helen Chen , Indian Cdmos , Rishika Sadam , Tommy Erdei , Michele Gershberg , Piramal Pharma , Peter Deyoung , Ashish Nimgaonkar , Ramesh Subramanian , Maggie Fick , Catherine Evans , Andrew Silver , Aragen Life Sciences , Sai Life Sciences , Piramal Pharma Solutions , Drug Administration , Glyscend Therapeutics , Greater China Managing Partner , Mordor Intelligence , Life Sciences ,

Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, a move that is benefiting rivals in India, according to interviews with 10 industry executives and experts. China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there. That is leading some biotech companies to consider using manufacturers in India to produce active pharmaceutical ingredient (API) for clinical trials or other outsourced work. ....

City Of , United Kingdom , Andhra Pradesh , United States , Maggie Fick , Catherine Evans , Ramesh Subramanian , Rishika Sadam , Indian Cdmos , Piramal Pharma , Andrew Silver , Michele Gershberg , Tommy Erdei , Ashish Nimgaonkar , Helen Chen , Peter Deyoung , Aragen Life Sciences , Sai Life Sciences , Drug Administration , Piramal Pharma Solutions , Glyscend Therapeutics , Greater China Managing Partner , Mordor Intelligence , Life Sciences , Clinical Trials , R Ashish Nimgaonkar ,